RELATIVE RISK OF CARDIOVASCULAR AND THROMBOTIC EVENTS AMONG PATIENTS WITH GIANT CELL ARTERITIS COMPARED WITH RHEUMATOID ARTHRITIS AND MATCHED CONTROLS: A COHORT STUDY USING US CLAIMS DATA

被引：0
|
作者：
Krueger, W. [1 ]
Yue, X. [1 ]
Lagunes, I. [1 ]
Setty, A. [1 ]
Ponte, C. [2 ,3 ]
Romero., A. [1 ]
机构：
[1] AbbVie Inc, N Chicago, IL USA
[2] Ctr Hosp Univ Lisboa Norte EPE, Rheumatol, Lisbon, Portugal
[3] Inst Med Mol, Rheumatol Res Unit, Lisbon, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
D O I：
10.1136/annrheumdis-2024-eular.2296
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0964
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
    Ogdie, Alexis
    Yu, YiDing
    Haynes, Kevin
    Love, Thorvardur Jon
    Maliha, Samantha
    Jiang, Yihui
    Troxel, Andrea B.
    Hennessy, Sean
    Kimmel, Steven E.
    Margolis, David J.
    Choi, Hyon
    Mehta, Nehal N.
    Gelfand, Joel M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 326 - 332
  • [12] A survey of traditional Chinese medicine use among rheumatoid arthritis patients: a claims data–based cohort study
    Ming-Chi Lu
    Hanoch Livneh
    Lei-Mei Chiu
    Ning-Sheng Lai
    Chia-Chou Yeh
    Tzung-Yi Tsai
    Clinical Rheumatology, 2019, 38 : 1393 - 1400
  • [13] Serious Cardiovascular Events Risk Factors In Giant Cell Arteritis. A Population-Based Study In The French Apogee Cohort
    Pugnet, Gregory
    Sailler, Laurent
    Moulis, Guillaume
    Fournier, Jean-Pascal
    Bourrel, Robert
    Montastruc, Jean-Louis
    Lapeyre-Mestre, Maryse
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S708 - S709
  • [14] Risk Of Cardiovascular Disease Among Patients With Psoriatic Arthritis Compared To Ankylosing Spondylitis (retrospective cohort study)
    Abbas, Zohair
    Magrey, Marina N.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S144 - S144
  • [15] A survey of traditional Chinese medicine use among rheumatoid arthritis patients: a claims data-based cohort study
    Lu, Ming-Chi
    Livneh, Hanoch
    Chiu, Lei-Mei
    Lai, Ning-Sheng
    Yeh, Chia-Chou
    Tsai, Tzung-Yi
    CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1393 - 1400
  • [16] Acute Cardiovascular Events Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a Nationwide Cohort Study: RELATION Study
    gottenberg, jacques-eric
    Mammar, Nadir
    Kessouri, Meriem
    Rudant, Jeremie
    Assi, nada
    grenier, Benjamin
    kirchgesner, julien
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2816 - 2819
  • [17] ACUTE CARDIOVASCULAR EVENTS RISK IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB OR TNF INHIBITORS, A NATIONWIDE COHORT STUDY: RELATION STUDY
    Gottenberg, J. E.
    Kessouri, M.
    Rudant, J.
    Assi, N.
    Grenier, B.
    Kirchgesner, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 402 - 402
  • [18] Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
    Solomon, Daniel H.
    Liu, Chih-Chin
    Kuo, I-Hsin
    Zak, Agnes
    Kim, Seoyoung C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (09) : 1674 - 1679
  • [19] Serious Infection Risk in Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Rheumatic Diseases: A US National Cohort Study
    Mehta, Bella Y.
    Pedro, Sofia
    Ozen, Gulsen
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [20] Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort in a multinational study: Study design and comparability of cohorts
    Fortuny, Joan
    Gilsenan, Alicia
    Cainzos-Achirica, Miguel
    Cantero, Oscar F.
    Flynn, Robert W. V.
    Garcia-Rodriguez, Luis
    Kollhorst, Bianca
    Karlsson, Par
    Linner, Love
    MacDonald, Thomas M.
    Plana, Estel
    Ruigomez, Ana
    Schink, Tania
    Ziemiecki, Ryan
    Andrews, Elizabeth B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 306 - 306
12345